IFP Advisors Inc Boosts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

IFP Advisors Inc grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 952 shares of the biotechnology company’s stock after buying an additional 67 shares during the period. IFP Advisors Inc’s holdings in Axon Enterprise were worth $566,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Colonial River Investments LLC boosted its position in shares of Axon Enterprise by 5.5% during the 4th quarter. Colonial River Investments LLC now owns 1,573 shares of the biotechnology company’s stock worth $935,000 after purchasing an additional 82 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in shares of Axon Enterprise by 16.2% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 12,200 shares of the biotechnology company’s stock worth $7,251,000 after purchasing an additional 1,700 shares during the period. Howard Capital Management Inc. purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $313,000. WESPAC Advisors LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $897,000. Finally, Wealthspire Advisors LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $220,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock valued at $5,631,561 in the last ninety days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 0.6 %

NASDAQ AXON opened at $528.45 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm’s fifty day moving average price is $609.55 and its 200 day moving average price is $523.20. The company has a market capitalization of $40.30 billion, a price-to-earnings ratio of 136.55, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of research analyst reports. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective for the company. in a research report on Thursday, February 20th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Robert W. Baird increased their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.